PharmaCyte Biotech, Inc.
NASDAQPMCB short interest surges 442% in one week to 439,272 shares, with cost to borrow climbing to 72.4% as availability plummets 91% to 371.6%.
Snapshot as of 28 Jun 2026
No long-form analysis yet for PMCB. Pulse alerts and the live data picture are available on ORTEX.
Open PMCB on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for PMCB — free to start on ORTEX.
Sign up for free →Open PMCB on ORTEX